Primary prophylaxis of bacterial infections and Pneumocystis jirovecii pneumonia in patients with hematological malignancies and solid tumors
Published 2013 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Primary prophylaxis of bacterial infections and Pneumocystis jirovecii pneumonia in patients with hematological malignancies and solid tumors
Authors
Keywords
Prophylaxis, Bacterial infection, Pneumocystis, Neutropenia
Journal
ANNALS OF HEMATOLOGY
Volume 92, Issue 4, Pages 433-442
Publisher
Springer Nature
Online
2013-02-14
DOI
10.1007/s00277-013-1698-0
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Myeloid Growth Factors
- (2017) Jeffrey Crawford et al. Journal of the National Comprehensive Cancer Network
- Antimicrobial therapy of febrile complications after high-dose chemotherapy and autologous hematopoietic stem cell transplantation—guidelines of the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Oncology (DGHO)
- (2012) Florian Weissinger et al. ANNALS OF HEMATOLOGY
- Changing aetiology, clinical features, antimicrobial resistance, and outcomes of bloodstream infection in neutropenic cancer patients
- (2012) C. Gudiol et al. CLINICAL MICROBIOLOGY AND INFECTION
- Clinical Impact of Antimicrobial Resistance in European Hospitals: Excess Mortality and Length of Hospital Stay Related to Methicillin-ResistantStaphylococcus aureusBloodstream Infections
- (2011) Marlieke E. A. de Kraker et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Risk of infection in patients with lymphoma receiving rituximab: systematic review and meta-analysis
- (2011) Simone Lanini et al. BMC Medicine
- Clinical Practice Guideline for the Use of Antimicrobial Agents in Neutropenic Patients with Cancer: 2010 Update by the Infectious Diseases Society of America
- (2011) Alison G. Freifeld et al. CLINICAL INFECTIOUS DISEASES
- Survival in neutropenic patients with severe sepsis or septic shock*
- (2011) Matthieu Legrand et al. CRITICAL CARE MEDICINE
- Fluoroquinolones, antimicrobial resistance and neutropenic cancer patients
- (2011) Eric James Bow CURRENT OPINION IN INFECTIOUS DISEASES
- Use of antibacterial prophylaxis for patients with neutropenia
- (2011) M. A. Slavin et al. INTERNAL MEDICINE JOURNAL
- Efficacy and safety of moxifloxacin as antibacterial prophylaxis for patients receiving autologous haematopoietic stem cell transplantation: a randomised trial
- (2011) J. Janne Vehreschild et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Clinical impact of fluoroquinolone prophylaxis in neutropenic patients with hematological malignancies
- (2011) Yong Chong et al. INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES
- Perils of quinolone exposure in cancer patients
- (2010) Gopi Rangaraj et al. CANCER
- 2010 update of EORTC guidelines for the use of granulocyte-colony stimulating factor to reduce the incidence of chemotherapy-induced febrile neutropenia in adult patients with lymphoproliferative disorders and solid tumours
- (2010) M.S. Aapro et al. EUROPEAN JOURNAL OF CANCER
- Does rituximab increase the incidence of infectious complications? A narrative review
- (2010) Theodoros Kelesidis et al. INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES
- Burden of antimicrobial resistance in European hospitals: excess mortality and length of hospital stay associated with bloodstream infections due to Escherichia coli resistant to third-generation cephalosporins
- (2010) M. E. A. de Kraker et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Addition of rituximab to fludarabine and cyclophosphamide in patients with chronic lymphocytic leukaemia: a randomised, open-label, phase 3 trial
- (2010) M Hallek et al. LANCET
- Clinical outcomes of health-care-associated infections and antimicrobial resistance in patients admitted to European intensive-care units: a cohort study
- (2010) Marie-Laurence Lambert et al. LANCET INFECTIOUS DISEASES
- Audit of fluoroquinolone prophylaxis against chemotherapy-induced febrile neutropenia in a hospital with highly prevalent fluoroquinolone resistance
- (2010) Esther Shu-Ting Ng et al. LEUKEMIA & LYMPHOMA
- The impact of a change in antibacterial prophylaxis from ceftazidime to levofloxacin in allogeneic hematopoietic cell transplantation
- (2009) K A Guthrie et al. BONE MARROW TRANSPLANTATION
- Infections in Patients with Multiple Myeloma in the Era of High‐Dose Therapy and Novel Agents
- (2009) Marcio Nucci et al. CLINICAL INFECTIOUS DISEASES
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started